Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Muggia

Showing results (311-320 of 424) with videos related to

Pageof 43
Sort By:
The Journal of Surgical Research|April 1, 1985
A possible beneficial effect of metronidazole in reducing TPN-associated liver function derangementsH R Freund, M Muggia-Sullam, R LaFrance, et al.
Environmental Health Perspectives|November 1, 1992
Cisplatin-DNA damage and repair in peripheral blood leukocytes in vivo and in vitroM Dabholkar, L Bradshaw, R J Parker, et al.
Carcinogenesis|July 1, 1991
Platinum-DNA damage in leukocyte DNA of patients receiving carboplatin and cisplatin chemotherapy, measured by atomic absorption spectrometryR J Parker, I Gill, R Tarone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Phase I and pharmacologic study of estramustine phosphate and short infusions of paclitaxel in women with solid tumorsA A Garcia, S Keren-Rosenberg, D Parimoo, et al.
Cancer Treatment Reports|February 1, 1986
Activity of epirubicin in pancreatic carcinomaH Hochster, M D Green, J L Speyer, et al.
Seminars in Oncology|August 1, 1995
Paclitaxel 3-hour infusion given alone and combined with carboplatin: preliminary results of dose-escalation trialsF M Muggia, D Vafai, R Natale, et al.
European Journal of Cancer|February 1, 1981
Current results of the screening program at the Division of Cancer Treatment, National Cancer InstituteA Goldin, J M Venditti, J S Macdonald, et al.
Cancer Investigation|January 1, 1995
Phase II clinical trial of carboplatin, ifosfamide, with oral mesna for metastatic breast carcinomaM Turrill, D V Spicer, A S Kelley, et al.
American Journal of Clinical Oncology|October 1, 1985
A phase II study of bisantrene in advanced refractory breast cancer. An Eastern Cooperative Oncology Group pilot studyK J Pandya, F M Muggia, R T Skeel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 5, 2003
Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactionsA Chanan-Khan, J Szebeni, S Savay, et al.
Pageof 43

Showing results (311-320 of 424) with videos related to

Sort By:
Pageof 43
The Journal of Surgical Research|April 1, 1985
A possible beneficial effect of metronidazole in reducing TPN-associated liver function derangementsH R Freund, M Muggia-Sullam, R LaFrance, et al.
Environmental Health Perspectives|November 1, 1992
Cisplatin-DNA damage and repair in peripheral blood leukocytes in vivo and in vitroM Dabholkar, L Bradshaw, R J Parker, et al.
Carcinogenesis|July 1, 1991
Platinum-DNA damage in leukocyte DNA of patients receiving carboplatin and cisplatin chemotherapy, measured by atomic absorption spectrometryR J Parker, I Gill, R Tarone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Phase I and pharmacologic study of estramustine phosphate and short infusions of paclitaxel in women with solid tumorsA A Garcia, S Keren-Rosenberg, D Parimoo, et al.
Cancer Treatment Reports|February 1, 1986
Activity of epirubicin in pancreatic carcinomaH Hochster, M D Green, J L Speyer, et al.
Seminars in Oncology|August 1, 1995
Paclitaxel 3-hour infusion given alone and combined with carboplatin: preliminary results of dose-escalation trialsF M Muggia, D Vafai, R Natale, et al.
European Journal of Cancer|February 1, 1981
Current results of the screening program at the Division of Cancer Treatment, National Cancer InstituteA Goldin, J M Venditti, J S Macdonald, et al.
Cancer Investigation|January 1, 1995
Phase II clinical trial of carboplatin, ifosfamide, with oral mesna for metastatic breast carcinomaM Turrill, D V Spicer, A S Kelley, et al.
American Journal of Clinical Oncology|October 1, 1985
A phase II study of bisantrene in advanced refractory breast cancer. An Eastern Cooperative Oncology Group pilot studyK J Pandya, F M Muggia, R T Skeel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 5, 2003
Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactionsA Chanan-Khan, J Szebeni, S Savay, et al.
Pageof 43